AC Immune
Romain Ollier is an experienced scientist specializing in antibody engineering, currently serving as a Senior Scientist at AC Immune. Prior to this role, Romain held positions at Merck KGaA in Darmstadt, Germany, including QC Manager in the Project and Equipment group and QC Project Engineer. Romain's background also includes significant contributions as a Principal Scientist and Research Officer at Glenmark Pharmaceuticals, as well as roles as a Research Associate at Antitope Ltd and research internships at AFMB CNRS UMR6098.
This person is not in the org chart
This person is not in any teams
AC Immune
3 followers
AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.